Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRW57
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,823
Award facts
- Contract value 100% obligated
- $11,823.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,823.41 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, representing a specialized pharmaceutical procurement aligned with military healthcare requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting global military healthcare operations and enables the company to fulfill federal medical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal requirements through repeated competitive awards and maintains a significant role in the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRW57?
SPE2DB25FRW57 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FRW57 worth?
The government has obligated $11,823 on SPE2DB25FRW57.
Is contract SPE2DB25FRW57 an order under another contract?
Yes. SPE2DB25FRW57 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRW57 competed?
The extent of competition for SPE2DB25FRW57 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award